EE+ POEM Archive
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Patent Foramen Ovale Closure in Cryptogenic Stroke Reduces Recurrence Rate Compared With Antiplatelet Agents." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent_foramen_ovale_closure_in_cryptogenic_stroke_reduces_recurrence_rate_compared_with_antiplatelet_agents.
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent_foramen_ovale_closure_in_cryptogenic_stroke_reduces_recurrence_rate_compared_with_antiplatelet_agents. Accessed March 31, 2023.
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent_foramen_ovale_closure_in_cryptogenic_stroke_reduces_recurrence_rate_compared_with_antiplatelet_agents
Patent Foramen Ovale Closure in Cryptogenic Stroke Reduces Recurrence Rate Compared With Antiplatelet Agents [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent_foramen_ovale_closure_in_cryptogenic_stroke_reduces_recurrence_rate_compared_with_antiplatelet_agents.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
ID - 1314366
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314366/all/Patent_foramen_ovale_closure_in_cryptogenic_stroke_reduces_recurrence_rate_compared_with_antiplatelet_agents
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
